BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32698394)

  • 1. Identification of Prognostic Markers in Patients with Primary Vitreoretinal Lymphoma by Clustering Analysis Using Clinical Data.
    Tsubota K; Usui Y; Goto H
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32698394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
    Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
    Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
    Yonese I; Takase H; Yoshimori M; Onozawa E; Tsuzura A; Miki T; Mochizuki M; Miura O; Arai A
    Eur J Haematol; 2019 Feb; 102(2):191-196. PubMed ID: 30390359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
    Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
    Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case 01-2017 - Primary vitreoretinal lymphoma (PVRL): report of a case and update of literature from 1942 to 2016.
    Wang Y; Cheung DS; Chan CC
    Ann Eye Sci; 2017 Jul; 2():. PubMed ID: 30167573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
    Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
    Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary vitreoretinal lymphoma.
    Kalogeropoulos D; Vartholomatos G; Mitra A; Elaraoud I; Ch'ng SW; Zikou A; Papoudou-Bai A; Moschos MM; Kanavaros P; Kalogeropoulos C
    Saudi J Ophthalmol; 2019; 33(1):66-80. PubMed ID: 30930667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of primary vitreoretinal lymphoma.
    Arai A; Takase H; Yoshimori M; Yamamoto K; Mochizuki M; Miura O
    Cancer Sci; 2020 Apr; 111(4):1417-1421. PubMed ID: 32056332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent pseudohypopyon in association with primary vitreoretinal lymphoma: a case report.
    Kitao M; Hashida N; Nishida K
    BMC Ophthalmol; 2016 Jul; 16():103. PubMed ID: 27391815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostics and treatment of primary vitreoretinal lymphoma].
    Stübiger N; Kakkassery V; Gundlach E; Winterhalter S; Pleyer U
    Ophthalmologe; 2015 Mar; 112(3):223-30. PubMed ID: 25698590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma.
    Zhou M; Xu G
    Taiwan J Ophthalmol; 2016; 6(4):170-176. PubMed ID: 29018736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
    Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
    Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region.
    Ahmed AH; Foster CS; Shields CL
    JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.
    Venkatesh R; Bavaharan B; Mahendradas P; Yadav NK
    Clin Ophthalmol; 2019; 13():353-364. PubMed ID: 30858685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Vitreoretinal Lymphoma: A Retrospective Study of 20 Eyes.
    Luo JY; Yu ST; Xu XY; Lin XX; Luo RJ; Long CD
    J Ophthalmol; 2022; 2022():4522974. PubMed ID: 35814482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors related to central nervous system involvement of primary vitreoretinal lymphoma.
    Kim JY; Kim JJ; Kim RY; Kim M; Park YG; Park YH
    Graefes Arch Clin Exp Ophthalmol; 2024 Mar; ():. PubMed ID: 38446203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central Nervous System Progression in Primary Vitreoretinal Lymphoma with Bilateral and Unilateral Involvement: A Systematic Review and Meta-Analysis.
    van Rooij JLM; Tokarska KA; Ten Dam-van Loon NH; Wessels PH; Seute T; Minnema MC; Snijders TJ
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary vitreoretinal lymphoma].
    Jaehne D; Coupland SE
    Ophthalmologe; 2018 Apr; 115(4):343-356. PubMed ID: 29589147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary vitreoretinal lymphoma: an update on pathogenesis, diagnosis and treatment.
    Reichstein D
    Curr Opin Ophthalmol; 2016 May; 27(3):177-84. PubMed ID: 26859131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary T-cell Vitreoretinal Non-Hodgkin Lymphoma: A Case Report and Literature Review.
    Low A; Chow RC; Ee Ling A; Khaliddin N
    Cureus; 2023 Jul; 15(7):e41341. PubMed ID: 37546106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.